Google venture arm backs UK universal flu vaccine company

LONDON (Reuters) - A private British company developing a vaccine that would be the first in the world to fight all types of flu has raised 20 million pounds ($27 million) from investors including GV, the venture capital arm of Google parent Alphabet Inc.